C3AR1 anticorps (AA 1-482)

N° du produit ABIN513867

Détail du produit anti-C3AR1 anticorps

Antigène: C3AR1 (Complement Component 3a Receptor 1 (C3AR1))

Épitope: AA 1-482

Reactivité: Humain

Hôte: Souris

Clonalité: Polyclonal

Conjugué: Cet anticorp C3AR1 est non-conjugé

Application: Western Blotting (WB), Flow Cytometry (FACS)

Fonction: Mouse polyclonal antibody raised against a full-length human C3AR1 protein.

Séquence: MASFSAETNS TDLLSQPWNE PPVILSMVIL SLTFLLGLPG NGLVLWVAGL KMQRTVNTIW FLHLTLADLL CCLSLPFSLA HLALQGQWPY GRFLCKLIPS IIVLNMFASV FLLTAISLDR CLVVFKPIWC QNHRNVGMAC SICGCIWVVA FVMCIPVFVY REIFTTDNHN RCGYKFGLSS SLDYPDFYGD PLENRSLENI VQPPGEMNDR LDPSSFQTND HPWTVPTVFQ PQTFQRPSAD SLPRGSARLT SQNLYSNVFK PADVVSPKIP SGFPIEDHET SPLDNSDAFL STHLKLFPSA SSNSFYESEL PQGFQDYYNL GQFTDDDQVP TPLVAITITR LVVGFLLPSV IMIACYSFIV FRMQRGRFAK SQSKTFRVAV VVVAVFLVCW TPYHIFGVLS LLTDPETPLG KTLMSWDHVC IALASANSCF NPFLYALLGK DFRKKARQSI QGILEAAFSE ELTRSTHCPS NNVISERNST TV

Réactivité croisée: Humain

Attributs du produit: Antibody reactive against mammalian transfected lysate.

Immunogène: C3AR1 (NP_004045.1, 1 a.a. ~ 482 a.a) full-length human protein.

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: In 1x PBS, pH 7.4

Conseil sur la manipulation: Aliquot to avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Détails sur C3AR1

Antigène: C3AR1 (Complement Component 3a Receptor 1 (C3AR1))

Autre désignation: C3AR1 (C3AR1 Produits)

Synonymes: anticorps C3AR, anticorps C3a-R, anticorps c3ar1, anticorps AZ3B, anticorps HNFAG09, anticorps C3a anaphylatoxin chemotactic receptor, anticorps complement C3a receptor 1, anticorps complement component 3a receptor 1, anticorps c3ar1, anticorps C3AR1, anticorps C3ar1

Sujet: Full Gene Name: complement component 3a receptor 1
Synonyms: AZ3B,C3AR,HNFAG09

ID gène: 719

NCBI Accession: NM_004054

Pathways: Système du Complément